Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 42.00 | |
50 mg | In stock | $ 66.00 |
Description | KM02894 is a glutamate release inhibitor. Cancer cells release high levels of glutamate that can disrupt normal bone turnover, which can lead to cancer-induced bone pain.KM02894 may be used in the study of tumor-related diseases. |
Molecular Weight | 215.3 |
Formula | C7H9N3OS2 |
CAS No. | 116850-74-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30.0 mg/mL (139.3 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KM02894 116850-74-9 Neuroscience GluR KM 02894 KM-02894 inhibitor inhibit